IGM Biosciences, Inc. (IGMS)
Chart Events
Performance Outlook
| Previous Close | 7.46 |
| Open | 7.48 |
| Bid | 7.13 x 900 |
| Ask | 7.19 x 800 |
| Day's Range | 7.11 - 7.50 |
| 52 Week Range | 6.45 - 28.20 |
| Volume | |
| Avg. Volume | 265,728 |
| Market Cap | 415.564M |
| Beta (5Y Monthly) | -0.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.40 |
| Earnings Date | Nov 01, 2023 - Nov 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.09 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for IGMS
Related Research
- IGM Biosciences, Inc.Daily – Vickers Top Buyers & Sellers for 07/05/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat3 months agoArgus Research
ZacksOrchard Therapeutics PLC Sponsored ADR (ORTX) Soars 12.9%: Is Further Upside Left in the Stock?
Orchard Therapeutics PLC Sponsored ADR (ORTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GlobeNewswireIGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
MOUNTAIN VIEW, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023, at 9:30 a.m. EDT. A live audio webcast of the event will be available on the “Events and Presentations” page
TipRanksDown More Than 50%: These 2 ‘Strong Buy’ Stocks Are Too Cheap to Ignore
Who doesn’t love a bargain? Buying quality for a low price is one of the thrills of the market system – and that applies to stock markets as well. The trick is knowing which rock-bottom stocks are the right ones to buy. Plenty of stocks are priced low, and bargain-hunting investors need to find the ones whose fundamentals are sound. The sheer volume of stocks, and the reams of data they produce, makes that difficult – but Wall Street analysts make their living by taking deep dives behind the sce
